Arbutus Biopharma Corp (ABUS)

Investing Cash Flow

-$10.84M

TTM · Period ending: · USD

ABUS logo

ABUS Investing Cash Flow

Latest reported-$10.84M
ABUS TTM Cash from Investing ($3.25M → -$10.84M)
High-resolution chart · PNG

ABUS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arbutus Biopharma Corp Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-10,842,000
6,430,000
15,580,000
30,352,000
28,385,000
22,603,000
22,948,000
31,762,000
54,177,000
45,789,000
50,773,000
41,230,000
17,063,000
1,792,000
-74,942,000
-95,745,000
-66,038,000
-90,955,000
-12,678,000
-54,533,000
-56,405,000
5,713,000
-14,909,000
-23,755,000
-21,697,000
-35,096,000
28,338,000
131,944,000
140,167,000
145,175,000
8,476,000
-35,599,000
-54,672,000
-71,042,000
27,819,000
27,841,000
21,656,000
-62,347,000
-99,124,000
-101,659,000
-118,512,000
-43,446,000
7,682,000
10,544,000
27,834,000
-5,077,000
-42,958,000
-44,210,898
-43,887,292
-855,765
-723,761
-530,818
-408,896
-214,151
-11,995
-14,091
-12,733
-2,433
-58,448
-88,058
-181,510
-345,616
-830,815
11,214,399
11,482,289
-597,200
3,849,677
-9,038,075
-7,081,365
7,613,103
3,245,346
3,879,830
1,492,549
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.